Mechanism of drug inhibition and drug resistance of influenza A M2 channel (Proceedings of the National Academy of Sciences of the United States of America (2009) 106, 18, (7379-7384) DOI: 10.1073/pnas.0902548106);Mechanism of drug inhibition and drug resistance of influenza A M2 channel

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 18, 2009, Pages 7379-7384

  Pielak, Rafal M ^a,b   Schnell, Jason R ^c   Chou, James J ^a  

^a Department of Biological Chemistry and Molecular Pharmacology ^*  (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

NMR; S31N; Structure

Indexed keywords

ALANINE; ASPARAGINE; LIPOSOME; PROTEIN M2; RIMANTADINE; SERINE; ADAMANTANE; ANTIVIRUS AGENT; M2 PROTEIN, INFLUENZA A VIRUS; MATRIX PROTEIN;

AMINO ACID SUBSTITUTION; ARTICLE; BINDING SITE; CROSS LINKING; DRUG BINDING; DRUG INHIBITION; DRUG RESISTANCE; DRUG SENSITIVITY; FOWL; INFLUENZA VIRUS A H5N1; MUTAGENESIS; MUTANT; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN CONFORMATION; PROTEIN STABILITY; PROTEIN STRUCTURE; ANTIVIRAL RESISTANCE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; HUMAN; PROTEIN SECONDARY STRUCTURE;

AVES; INFLUENZA A VIRUS;

ADAMANTANE; ANTIVIRAL AGENTS; BINDING SITES; DRUG RESISTANCE, VIRAL; HUMANS; MODELS, MOLECULAR; PROTEIN CONFORMATION; PROTEIN STRUCTURE, SECONDARY; VIRAL MATRIX PROTEINS;

EID: 66149112971     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0905916106     Document Type: Erratum

References (25)

1. Bright RA, Shay DK, Shu B, Cox NJ, Klimov AI (2006) Adamantane resistance among;nfluenza A viruses;solated early during the 2005-2006 influenza season in the United States. J Am Med Assoc 295:891-894.
2. Schnell JR, Chou JJ (2008) Structure and mechanism of the M2 proton channel of influenza Avirus. Nature 451:591-595.
3. Pinto LH, et al. (1997) A functionally defined model for the M2 proton channel of influenza Avirus suggests a mechanism for its ion selectivity. Proc Natl Acad Sci USA 94:11301-11306.
4. KovacsFA, Denny JK, Song Z,QuineJR, Cross TA (2000) Helixtiltof the M2 transmembrane peptide from influenza Avirus: An intrinsic property. J Mol Biol 295:117-125.
5. Stouffer AL, et al. (2008) Structural basis for the function and inhibition of an influenza virus proton channel. Nature 451:596-599.
6. Tang Y, Zaitseva F, Lamb RA, Pinto LH (2002) The gate of the influenza virus M2 proton channel is formed by a single tryptophan residue. J Biol Chem 277:39880-39886.
7. Wang C, Lamb RA, Pinto LH (1995) Activation of the M2 ion channel of influenza virus: A role for the transmembrane domain histidine residue. Biophys J 69:1363-1371.
8. Aldrich PE, et al. (1971) Antiviral agents. 2. Structure-activity relationships of compounds related to 1-adamantanamine. J Med Chem 14:535-543.
9. Huang RB, Du QS, Wang CH, Chou KC (2008) An in-depth analysis of the biological functional studies based on the NMR M2 channel structure of influenza Avirus. Biochem Biophys Res Commun 377:1243-1247.
10. Nguitragool W, Miller C (2006) Uncoupling of a CLC Cl-/H+ exchange transporter by polyatomic anions. J Mol Biol 362:682-690.
11. Lin TI, Schroeder C (2001) Definitive assignment of proton selectivity and attoampere unitary current to the M2 ion channel protein of influenza Avirus. J Virol 75:3647-3656.
12. Moffat JC, et al. (2008) Proton transport through influenza Avirus M2 protein reconstituted in vesicles. Biophys J94:434-445.
13. Schroeder C, Ford CM, Wharton SA, Hay AJ (1994) Functional reconstitution in lipid vesicles of influenza virus M2 protein expressed by baculovirus: Evidence for proton transfer activity. J Gen Virol 75:3477-3484.
14. Helenius A (1992) Unpacking the incoming influenza virus. Cell 69:577-578.
15. Call ME, et al. (2006) The structure of the zetazeta transmembrane dimer reveals features essential for its assembly with the T cell receptor. Cell 127:355-368.
16. Chizhmakov IV, et al. (2003) Differences in conductance of M2 proton channels of two influenza viruses at low and high pH. J Physiol 546:427-438.
17. Betakova T, Ciampor F, Hay AJ (2005) influence of residue 44 on the activity of the M2 proton channel of influenza A virus. J Gen Virol 86:181-184.
18. Jing X, et al. (2008) Functional studies indicate amantadine binds to the pore of the influenza A virus M2 proton-selective ion channel. Proc Natl Acad Sci USA 105:10967-10972.
19. Walters RF, DeGrado WF (2006) Helix-packing motifs in membrane proteins. Proc Natl Acad Sci USA 103:13658-13663.
20. Ito T, Gorman OT, Kawaoka Y, Bean WJ, Webster RG (1991) Evolutionary analysis of the influenza Avirus M gene with comparison of the M1 and M2 proteins. J Virol 65:5491-5498.
21. Wang C, Takeuchi K, Pinto LH, Lamb RA (1993) ion channel activity of influenza Avirus M2 protein: Characterization of the amantadine block. J Virol 67:5585-5594.
22. Shimbo K, Brassard DL, Lamb RA, Pinto LH (1995) Viral and cellular small integral membrane proteins can modify ion channels endogenous to Xenopus oocytes. Biophys J 69:1819-1829.
23. Salzmann M, Wider G, Pervushin K, Wuthrich K (1999) improved sensitivity and coherence selection for [N-15,H-1]-TROSY elements in triple resonance experiments. J Biomol NMR 15:181-184.
24. Kay LE, Ikura M, Tschudin R, Bax A (1990) Three-dimensional triple resonance NMR spectroscopy of isotopically enriched proteins. J Magn Reson 89:496-514.
25. Schwieters CD, Kuszewski J, Tjandra N, Clore GM (2002) The Xplor-NIH NMR molecular structure determination package. J Magn Reson 160:66-74.